Quelles sont les heures d'ouverture ?

Lundi 08:30 - 17:00 Mardi 08:30 - 17:00 Mercredi 08:30 - 17:00 Jeudi 08:30 - 17:00 Vendredi 08:30 - 17:00

European Cancer Organisation

Page d'Accueil
België
Brussels
European Cancer Organisation

Working together to build consensus and achieve improvement in cancer care.

The European Cancer Organisation

Our Mission

To reduce the burden of cancer, improve outcomes and the quality of care for cancer patients, through multidisciplinarity and multiprofessionalism. As the not-for-profit federation of member organisations working in cancer at a European level, we convene oncology professionals and patients to agree policy, advocate for positive change and be the united voice of the European cancer community. Our Vision

To be a vibrant, pro-active, focused, relevant and influential federation, working together for a cancer free future, ensuring that every patient has high quality care and treatment, with access to the full range of professionals needed. To create and develop ever-strengthening relationships between European institutions and the European cancer care community, and with our Member Societies and networks, facilitate collaboration and consensus on focused topics towards tangible and impactful policy improvement. Our Values

Our essential and enduring values are:

-Patient Centricity – Putting cancer patients at the centre of our concerns and activities and strive to do the best for them

- Commitment to Science – Reflecting the very latest scientific knowledge and be completely independent of any vested interests

- Cohesiveness – We believe in the power of combining the efforts of our members and other stakeholders who have a common mission

- Inclusiveness – We seek to include all non-profit organisations that share our mission, vision and values

- Equality and Fairness – All our members have a voice in the organisation and we strive to transcend the interests of any one member

- Openness and Transparency – We are committed to be transparent in and accountable for all that we do

17/09/2026

The European Parliament is calling on the European Commission and EU Member States to adopt a new plan to address the crisis in Europe's health workforce

The initiative calls for:

👉️a comprehensive, long-term strategy that includes increasing the workforce by at least one million professionals during the next budget period (2028–2034);

👉️making the protection of staff mental health a key performance indicator within health systems;

👉️reviewing and modernising the EU Professional Qualifications Directive to better meet the needs of healthcare professionals; and

👉️establishing an EU monitoring system to anticipate healthcare workforce supply and demand.

These priorities closely reflect the evidence and recommendations that ECO and the wider cancer community have brought forward through our Time to Accelerate for our Workforce campaign and our Under Pressure report.

Today’s vote is an important first step. The focus must now turn to implementation and ensuring that Europe has the people, planning and working conditions needed to deliver high-quality cancer care. We hope the European Commission and EU Member States are in listening mode.

Learn more about the oncology workforce crisis: https://www.europeancancer.org/workforce-crisis.html

17/09/2026

The human papillomavirus (HPV) causes almost 100,000 cancer cases in the EU each year, while hepatitis B is responsible for 12,000 cases of liver cancer. 📊

So how can Europe accelerate progress towards eliminating these cancers?

This session will explore how stronger vaccination and screening strategies, combined with tackling stigma, can help.

Join leading experts to discover:

✅ How to strengthen HPV and hepatitis B vaccination and screening programmes
✅ Why addressing stigma is essential to improving uptake
✅ How ECO's latest policy tools, including the HPV Atlas, HPV Vaccination Guide and Hepatitis B Policy Paper, can support policymakers and health authorities in driving meaningful change

Be part of the conversation on building a healthier future through better prevention and smarter policy.

📅 18-19 November | followed on 20 November by two EU-funded project events
📍 Brussels & online

Secure your spot today 🔗 europeancancer.org/summit

17/09/2026

🚀 A new European research project is exploring a different way of delivering cancer treatment.

will investigate aerosolised chemotherapy for people whose cancer has spread within the abdomen or around the lungs, delivering treatment directly to the affected area as a fine aerosol. 💨

Through three European clinical trials, the project will assess effectiveness, safety and quality of life, while also looking at patient needs, cost-effectiveness and future implementation. 🧪👥

ECO is pleased to be part of this six-year collaboration.

👉 Discover IMPACT: https://eu-impact.org/

17/09/2026

What comes next for inter-speciality cancer training in Europe?

On Friday 20 November, Europe’s cancer community will come together to move the conversation from successful implementation to lasting impact.

The European Conference on Inter-Speciality Cancer Training & Care will explore the experience of and how stronger collaboration, skills and shared learning can expand person-centred cancer care across Europe.

Join us in Brussels or online.

🔗 Request registration: https://www.europeancancer.org/events/441:isct-conference.html

16/09/2026

📢 Join us for this live webinar!

Empowering People, Transforming Cancer Care: Advancing Health Literacy Across Europe

🗓️ 21 September 2026
🕒 15:00–16:00 CET
💻 Online

This webinar will bring together five projects devoted to improving cancer literacy. We’ll share approaches, evidence and good practices, while exploring opportunities for greater collaboration and impact across Europe.

ECO is a partner of , which will showcase development of its Health Literacy Hub, including a virtual library and a health literacy training programme for healthcare professionals, patients and citizens.

Join us for the discussion.

👉 Register now: https://ecconf.webex.com/weblink/register/rb72e1945d5a57f0e9fedd40e72495d9a

16/09/2026

What does meaningful patient involvement in cancer research really look like? 🤝
At the Quality of Life and Cancer Policy Forum, our first session will explore how researchers and patients can work together to shape research priorities, methods and outcomes. 🔍

The discussion will look at what meaningful collaboration requires, what still gets in the way, and how stronger standards for public and patient involvement can improve quality of life and patient-centred care.

Speakers include:
👤 Merel Engelaar, NIVEL
👤 Laura Pinnavaia, EUonQoL
👤 Michelle Edwards, SERENITY
👤 Chelsea Vinckier, EU NAVIGATE
👤 Bettina Ryll, Melanoma Patient Network Europe

When and where? 👇
📅 20 November 2026
📍 The Hotel Brussels & online
🔗 Apply for registration: https://europeancancer.org/qolforum

16/09/2026

Today is World Lymphoma Awareness Day. 🌍

We recognise World Lymphoma Awareness Day on 15 September because lymphoma is the world's leading blood cancer. It needs special attention because it is the 9th most commonly diagnosed cancer globally, and some subtypes are associated with a high mortality rate.

This year’s campaign, Navigating Lymphoma and CLL Together, shines a light on the common challenges people face related to their diagnosis, treatment, survivorship and beyond. It also recognises the important role patient organisations play as trusted guides, providing reliable information, practical support, education, and compassion at every stage of the journey.

Every lymphoma and CLL journey is different, but many of the challenges are shared. By speaking openly about these experiences and helping people connect with trusted support, we can make the journey feel less overwhelming.

Join the No Patient Travels Alone Pledge and help make the challenges people face more visible. Every story shared can help someone feel seen, understood, and less alone.

Together, we can help ensure that no patient travels alone.

Join the pledge:
https://lymphomacoalition.org/world-lymphoma-awareness-day/

16/09/2026

Innovation needs to understand the people it is designed to serve. 🧬🤝

From the start, SANGUINE has taken a multidisciplinary approach, bringing social sciences and humanities into the project, helping to consider human interaction, ethics and the real-world needs of patients and healthcare professionals.

At the SANGUINE Showcase Event, we will sit down with patients and patient representatives to hear their perspectives, experiences and expectations for the future of blood cancer diagnosis.

📅 13–14 October 2026
📍 Brussels, Belgium

Free registration is now open 🎟️ https://www.europeancancer.org/events/449:transforming-blood-cancer-detection-through-european-innovation.html

15/09/2026

🚨 Deadline Alert: The European Cancer Summit special registration rate ends today, 15 September.

Your voice belongs here. Experts, patients, and policymakers—your perspective matters. Join us to navigate the challenges ahead and keep cancer care at the heart of Europe’s agenda. Because if we don’t, who will?

The programme offers high-level, practical sessions, including:

➡️Cancer Control Plans & Return on Investment: Quantifying the economic and clinical returns of investing across the whole cancer pathway.

➡️Bridging the Rural–Urban Divide: Deploying changes at system level to narrow persistent gaps in care between remote and city populations.

➡️Safeguarding Care in Crisis: Protecting facilities, securing digital data, and maintaining continuity of treatment amid rising geopolitical uncertainty.

➡️Europe's Clinical Trials Landscape: Streamlining regulatory pathways to accelerate patient access to cutting-edge therapies.

➡️Inclusive Leadership: Breaking down workforce barriers to build leadership teams that are diverse and culturally responsive.

Register now 🔗 https://europeancancer.org/summit

15/09/2026

Why do many men avoid cancer screening?
And how can we help overcome it?

For answers, join us for ‘From Detection, to Diagnosis, to Treatment: Men and Cancer Challenges’,

Together we’ll explore:

🔹 Why bladder cancer poses specific detection and diagnosis challenges for men, and how awareness, earlier recognition and stronger diagnostic pathways can help address them.

🔹 Why we need more and better organised, population- and risk-based prostate cancer screening programmes and more effective early detection pathways.

🗓️ Wednesday 23 September
🕞 15:00–17:30 CEST
📍 Online

Join the discussion:
🔗 https://europeancancer.org/events/450:men-and-cancer-distinct-challenges-distinct-opportunities.html

Adresse

Rue De La Science 41
Brussels
1040

Heures d'ouverture

Lundi	08:30 - 17:00
Mardi	08:30 - 17:00
Mercredi	08:30 - 17:00
Jeudi	08:30 - 17:00
Vendredi	08:30 - 17:00

Site Web

https://www.europeancancer.org/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque European Cancer Organisation publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.